Rover Diagnostics is developing an low-cost, simple-to-use, ultrafast point-of-care test for COVID-19. The Rover platform provides reverse transcription polymerase chain reaction (RT PCR) results in just eight minutes, faster than any other test of its kind.
Widely used since the 1980s in both clinical and research settings, RT PCR has been the gold standard for molecular diagnostic testing for decades. But traditional PCR, which requires up to 90 minutes of processing time and trained technicians to operate equipment, has meant that practical clinical use of the technology has mostly been limited to large, centralized labs.
The Rover LightSpeed testing system provides three key advantages over traditional PCR. It's much faster, more portable (about two pounds and smaller than a kitchen toaster), and doesn’t require a lab or trained technician. Therefore, it can be operated almost anywhere: in a doctor’s office or nursing home, at home or work, in a college dorm, at an airport, or even in a restaurant or theatre lobby. Rover’s system meets today’s urgent need for a cost-effective, highly sensitive, mass-produced field test kit.
In addition to COVID-19, Rover’s platform is designed to test for a broad range of infectious diseases, including flu, strep, and other time-sensitive viruses.